image
Healthcare - Biotechnology - NASDAQ - CH
$ 5.33
0.947 %
$ 223 M
Market Cap
-2.49
P/E
INCOME STATEMENT
7.04 M REVENUE
-96.29%
-61.1 M OPERATING INCOME
-52.40%
-62 M NET INCOME
-52.59%
EFFICIENCY
Earnings Waterfall Molecular Partners AG
image
Revenue 7.04 M
Cost Of Revenue 47.8 M
Gross Profit -40.8 M
Operating Expenses 20.3 M
Operating Income -61.1 M
Other Expenses 876 K
Net Income -62 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 7.0 189.6 9.3 9.3 20.4 10.4 20.0 23.0 29.1 26.6 32.4
GROSS PROFIT
Cost Of Revenue 47.8 50.7 55.7 56.1 43.5 15.6 17.8 14.6 1.2 0.2 1.2
Gross Profit (40.8) 138.8 (46.4) (46.7) (23.1) (5.2) 2.2 8.5 28.0 26.5 31.2
OPERATING INCOME
Operating Expenses 20.3 72.9 72.7 67.7 57.0 47.8 45.9 42.5 31.3 24.8 25.3
Selling, General and Administrative Expenses 19.0 21.8 16.9 11.0 13.2 9.5 8.3 7.2 6.2 4.9 3.6
Research and Development Expenses 48.8 50.7 55.7 56.1 43.5 38.2 37.5 35.2 23.9 18.8 20.8
Operating Income (61.1) 116.6 (63.4) (58.3) (36.7) (37.4) (25.8) (19.5) (2.2) 1.8 7.1
PRE-TAX INCOME
Interest Income Expense 49 K 0.6 0.5 0.3 27 K 0.6 0.2 89 K 216 853 0.2
Total Other Income (0.9) 1.2 (0.4) (4.4) 0.4 0.4 0.4 0.9 2.1 (4.1) 24.9 K
Pre-Tax Income (62.0) 117.9 (63.8) (62.8) (36.3) (37.0) (25.4) (18.6) (0.1) (2.3) 7.1
NET INCOME
Tax Provision 0 (1.2) 2 K 11 K 17 K (0.6) (0.4) (0.9) (2.1) 4.1 (0.2)
Net Income (62.0) 117.9 (63.8) (62.8) (36.3) (37.0) (25.4) (18.6) (0.1) (2.3) 7.1
EPS 1.89 3.63 2.06 2.51 1.69 1.75 1.22 0.91 0.0076 0.15 0.37